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Introduction {#os12572-sec-0005}
============

Obesity is a growing public health concern in the United States, with an estimation of 78 mn population considered to be obese (body mass index \[BMI\] ≥ 30 kg/m^2^) according to the Centers for Disease Control and Prevention[1](#os12572-bib-0001){ref-type="ref"}. Obesity has been associated with significant comorbidities, including heart disease, hypertension, stroke, diabetes, and obstructive sleep apnea[1](#os12572-bib-0001){ref-type="ref"}, [2](#os12572-bib-0002){ref-type="ref"}, [3](#os12572-bib-0003){ref-type="ref"}. All these not only increase the medical costs[4](#os12572-bib-0004){ref-type="ref"}, but also have a heavy burden on the surgical care, such as longer hospitalizations and higher rate of postoperative complications[5](#os12572-bib-0005){ref-type="ref"}, [6](#os12572-bib-0006){ref-type="ref"}.

A high BMI has adverse effects on spinal health, and this has been confirmed by increased rates of spinal degenerative disease among obese patients[7](#os12572-bib-0007){ref-type="ref"}. In terms of the cervical spine, obesity increased the risk of cervical myelopathy and radiculopathy[8](#os12572-bib-0008){ref-type="ref"}, [9](#os12572-bib-0009){ref-type="ref"}. Moreover, obesity is also a predictor of surgical outcomes, especially in those who underwent spine surgery. There were several published studies[5](#os12572-bib-0005){ref-type="ref"}, [10](#os12572-bib-0010){ref-type="ref"}, [11](#os12572-bib-0011){ref-type="ref"}, [12](#os12572-bib-0012){ref-type="ref"}, [13](#os12572-bib-0013){ref-type="ref"}, [14](#os12572-bib-0014){ref-type="ref"} that investigated the impact of obesity on outcomes following spine surgery; however, their results remained controversial. Some studies have demonstrated that obesity was associated with longer operative time, increased blood loss, and increased risk of complications during spinal surgery[5](#os12572-bib-0005){ref-type="ref"}, [10](#os12572-bib-0010){ref-type="ref"}, [11](#os12572-bib-0011){ref-type="ref"}, [12](#os12572-bib-0012){ref-type="ref"}, [13](#os12572-bib-0013){ref-type="ref"}. Whereas, another study reported opposite findings, which showed that obesity was not associated with less improvement in patient‐reported outcomes following anterior cervical discectomy and fusion (ACDF)[14](#os12572-bib-0014){ref-type="ref"}. In order to investigate whether high BMI had adverse effects on the surgical outcomes for patients who underwent anterior or posterior cervical fusion procedures, we conducted this meta‐analysis.

Materials and Methods {#os12572-sec-0006}
=====================

*Search Strategy* {#os12572-sec-0007}
-----------------

This meta‐analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐analysis (PRISMA) statement guidelines[15](#os12572-bib-0015){ref-type="ref"}. Since animal experiment or human was not involved in this study, the ethical approval was not necessary.

Relevant literatures published in PubMed, Embase, and Web of Science were systematically searched from their inception to 21 February 2019. Structured search strategies were listed as followings: obese, adiposity, body mass index, BMI, cervical spinal fusion (Appendix [S1](#os12572-supitem-0001){ref-type="supplementary-material"}). We did not impose any language limitation in the search strategy. Moreover, the reference lists of review and included studies were also checked manually to identify additional relevant articles.

*Study Inclusion Criteria and Exclusion Criteria* {#os12572-sec-0008}
-------------------------------------------------

Studies meeting the following inclusion criteria were included in this meta‐analysis: (i) population: adult patients who underwent anterior or posterior cervical fusion; (ii) variable of interest: high BMI; (iii) comparison: normal BMI; (iv) outcome: surgical time, length of hospital stay, blood loss, Neck Disability Index, SF‐36 PCS/MCS, mortality rate, and postoperative complications; and (v) study design: cohort study, case‐control study, or controlled or comparative studies. Studies were excluded that: (i) studies did not focus on topics of interest; (ii) did not involve any one of the outcomes; and/or (iii) were reviews, letters, or case reports. Disagreement between investigators were resolved by discussion and consensus.

*Data Extraction* {#os12572-sec-0009}
-----------------

A prestandardized data extraction form was used to extract data from the included studies. Two independent investigators performed the data extraction and the accuracy was checked by a third investigator. The following information was extracted from each study: author\'s name, publication year, country, study design, number of patients in each group, age, gender, surgical procedures, patient characteristics, and outcome measures.

*Methodological Assessment* {#os12572-sec-0010}
---------------------------

We assessed the methodological quality of a non‐randomized trial using the modified Newcastle‐Ottawa (NOS) scale[16](#os12572-bib-0016){ref-type="ref"}. This method consists of three items to evaluate the quality, including patient selection, comparability of the intervention/control group, and outcome assessment[16](#os12572-bib-0016){ref-type="ref"}. The total score was nine points, and studies with a score of more than five points were categorized as high quality[16](#os12572-bib-0016){ref-type="ref"}.

*Statistical Analysis* {#os12572-sec-0011}
----------------------

Data analysis was performed using the STATA software version 12.0 (Stata Corporation, College Station, TX, USA). We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous outcomes, and weight mean difference (WMD) with 95% CIs for continuous outcomes. Meta‐analyses were performed using a fixed‐effects model[17](#os12572-bib-0017){ref-type="ref"} or a random‐effects model[18](#os12572-bib-0018){ref-type="ref"}, according to the heterogeneity across the included studies. Statistical heterogeneity was assessed by Cochrane Q chi‐square test and I^2^ statistic[19](#os12572-bib-0019){ref-type="ref"}, in which A *P* value \< 0.1 or *I* ^2^ \> 50% represent significant heterogeneity. For the primary outcomes, subgroup analyses were carried out according to surgical procedures (anterior or posterior cervical fusions). BMI is defined as height (in meters) divided by weight (kilograms squared). Standard categories typically included normal weight (18.0--24.9 m/kg^2^), overweight (25.0--29.9 m/kg^2^), and obese (\>30.0 m/kg^2^). When patients were stratified by BMI, and subgroup analysis based on comparison between normal and higher BMI was present, we extracted the subgroup data for analysis. The publication bias was assessed using Begg[20](#os12572-bib-0020){ref-type="ref"} and Egger test[21](#os12572-bib-0021){ref-type="ref"}. A *P* value less than 0.05 was judged as statistically significant, except where otherwise specified.

Results {#os12572-sec-0012}
=======

*Search Strategy Results* {#os12572-sec-0013}
-------------------------

Our initial search yielded a total of 573 records, of which 247 records remained after 326 duplicates were removed. Then 237 were excluded after title and abstract review, and three were excluded after the full‐text review. Finally, seven studies[5](#os12572-bib-0005){ref-type="ref"}, [14](#os12572-bib-0014){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} were included in this meta‐analysis. The flow diagram of the literature search process was shown in Fig. [1](#os12572-fig-0001){ref-type="fig"}.

![Eligibility of studies for inclusion in meta‐analysis.](OS-12-3-g001){#os12572-fig-0001}

*Study Characteristics of Included Studies* {#os12572-sec-0014}
-------------------------------------------

The baseline characteristics of included studies is presented in Table [1](#os12572-tbl-0001){ref-type="table"}. All the studies were conducted in the USA, and were published between 2010 and 2018. All the studies[14](#os12572-bib-0014){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} were prospective or retrospective cohort studies except one[5](#os12572-bib-0005){ref-type="ref"}, which was a retrospective cross‐sectional study. Patients in three studies[22](#os12572-bib-0022){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"} were categorized into the following groups according to their BMI: underweight (\<18.5 kg/m^2^), normal weight (18.5--24.99 kg/m^2^), overweight (25--29.99 kg/m^2^), nonobese (18.5--29.9 kg/m^2^), obese I (30--34.9 kg/m^2^), obese II (35--39.9 kg/m^2^), or obese III (≥40 kg/m^2^). And in the remaining four studies[5](#os12572-bib-0005){ref-type="ref"}, [14](#os12572-bib-0014){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} patients were divided into two groups, however, the definition of obesity among them varied greatly, which was \>30, 35 or 40 kg/m^2^. Patients in four studies[14](#os12572-bib-0014){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} received ACDF, one[24](#os12572-bib-0024){ref-type="ref"} received posterior cervical fusion, and the remaining two[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"} received ACDF or posterior cervical fusion.

###### 

Baseline characteristics of patients in the trials included in the meta‐analysis

  Study                                                        Country   Publication year   Study design                          BMI (kg/m^2^)   No. of patients   type of surgical procedure       Male/female   Age (mean ± SD, year)   NOS score
  ------------------------------------------------------------ --------- ------------------ ------------------------------------- --------------- ----------------- -------------------------------- ------------- ----------------------- -----------
  Kalanithi *et al*.[5](#os12572-bib-0005){ref-type="ref"}     USA       2012               Retrospective cross‐sectional study   \<25.0          83,152            ACDF/posterior cervical fusion   NA            NA                      7
                                                                                                                                  ≥40             1455              ACDF/posterior cervical fusion   NA            NA                      
  Sielatycki *et al*.[14](#os12572-bib-0014){ref-type="ref"}   USA       2016               Prospective cohort                    \<35            219               ACDF                             124/95        52.8 ± 10.3             7
                                                                                                                                  ≥35             80                ACDF                             36/44         51.3 ± 9.2              
  Buerba *et al*.[22](#os12572-bib-0022){ref-type="ref"}       USA       2014               Retrospective cohort                  18.5--29.9      2072              ACDF                             1024/1003     NA                      7
                                                                                                                                  30--34.9        915               ACDF                             508/407       NA                      
                                                                                                                                  35--39.9        419               ACDF                             180/239       NA                      
                                                                                                                                  ≥40             265               ACDF                             97/168        NA                      
  Narain *et al*.[23](#os12572-bib-0023){ref-type="ref"}       USA       2018               Retrospective cohort                  \<25.0          58                ACDF                             29/29         49.5 ± 11.3             7
                                                                                                                                  25.0--29.9      104               ACDF                             60/44         48.8 ± 9.2              
                                                                                                                                  30.0--34.9      69                ACDF                             44/25         51.8 ± 11.2             
                                                                                                                                  ≥35.0           46                ACDF                             22/24         53.4 ± 11.2             
  Phan *et al*.[24](#os12572-bib-0024){ref-type="ref"}         USA       2017               Retrospective cohort                  ≤30             322               Posterior cervical fusion        184/138       NA                      7
                                                                                                                                  \>30            202               Posterior cervical fusion        103/99        NA                      
  Wilson *et al*.[25](#os12572-bib-0025){ref-type="ref"}       USA       2017               Retrospective cohort                  \<18.5          17                ACDF                             NA            NA                      6
                                                                                                                                  18.5--24.99     271               ACDF                             NA            NA                      
                                                                                                                                  25--29.99       275               ACDF                             NA            NA                      
                                                                                                                                  \>30            194               ACDF                             NA            NA                      
  Sami Walid *et al*.[26](#os12572-bib-0026){ref-type="ref"}   USA       2010               Retrospective cohort                  \<30            318               ACDF                             NA            NA                      6
                                                                                                                                  ≥30             287               ACDF                             NA            NA                      

ACDF, anterior cervical discectomy and fusion; BMI, body mass index; NA, not available; SD, standard deviation.

The NOS score in five studies[5](#os12572-bib-0005){ref-type="ref"}, [14](#os12572-bib-0014){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} was seven and in two[25](#os12572-bib-0025){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} was six, which indicated that these studies were of high quality.

*Length of Hospital Stay* {#os12572-sec-0015}
-------------------------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} with nine sets of data reported the data of length of hospital stay. Pooled results showed that high BMI was associated with a significantly longer hospital stay than normal BMI (WMD = 1.61 days, 95% CI: 0.51, 2.71; *P* = 0.004) (Fig. [2](#os12572-fig-0002){ref-type="fig"}). There was significant heterogeneity among the included studies (I^2^ = 50.4%, *P* = 0.040). When the outlier was removed, the pooled estimate changed a little (WMD = 1.81 days, 95% CI: 0.84, 2.78; *P* \< 0.001), and the heterogeneity was still present (I^2^ = 42.6%, *P* = 0.095).

![Forest plot showing the effect of high BMI on length of hospital stay.](OS-12-3-g002){#os12572-fig-0002}

*Surgical Time* {#os12572-sec-0016}
---------------

Two studies[22](#os12572-bib-0022){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"} with seven sets of data reported the data of surgical time. The pooled estimate suggested that high BMI was associated with a significantly longer surgical time than normal BMI (WMD = 4.55, 95% CI: 1.04, 8.07; *P* = 0.011) (Fig. [3](#os12572-fig-0003){ref-type="fig"}). The test for heterogeneity was significant (I^2^ = 99.6%, *P* \< 0.001). Thus, we conducted sensitivity. When the outlier was removed, the overall estimate did not change substantially (WMD = 4.94, 95% CI: 1.78, 7.66; *P* = 0.004), but the heterogeneity was still present (I^2^ = 99.3%, *P* \< 0.001).

![Forest plot showing the effect of high BMI on surgical time.](OS-12-3-g003){#os12572-fig-0003}

*Neck Disability Index* {#os12572-sec-0017}
-----------------------

Two studies[14](#os12572-bib-0014){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"} with six sets of data reported the Neck Disability Index. The pooled results showed that high BMI was associated with similar score in Neck Disability Index with normal BMI (WMD = 1.49, 95% CI: −2.34, 5.32; *P* = 0.447) (Fig. [4](#os12572-fig-0004){ref-type="fig"}). There was significant heterogeneity among the included studies (I^2^ = 72.1%, *P* = 0.003). When we excluded the outlier, the overall estimate changed a little (WMD = 2.64, 95% CI: −1.06, 6.34; *P* = 0.162), but the heterogeneity was still present (I^2^ = 66.8%, *P* = 0.017).

![Forest plot showing the effect of high BMI on Neck Disability Index.](OS-12-3-g004){#os12572-fig-0004}

*Overall Complications* {#os12572-sec-0018}
-----------------------

All the studies[5](#os12572-bib-0005){ref-type="ref"}, [14](#os12572-bib-0014){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [23](#os12572-bib-0023){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"}, [26](#os12572-bib-0026){ref-type="ref"} reported the data of overall complications. However, only four studies provided 10 sets of available data. Pooled estimate showed that high BMI was associated with a similar complication rate with normal BMI (RR=1.18, 95% CI: 0.80, 1.76; *P* = 0.399) (Fig. [5](#os12572-fig-0005){ref-type="fig"}).

![Forest plot showing the effect of high BMI on overall complications.](OS-12-3-g005){#os12572-fig-0005}

*SF‐36 PCS* {#os12572-sec-0019}
-----------

Two studies[14](#os12572-bib-0014){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"} with six sets of data reported the SF‐36 PCS. The aggregated results suggested that high BMI was associated with a significantly less score in SF‐36 PCS than normal BMI (WMD = −1.65, 95% CI: −2.91, −0.39; *P* = 0.010) (Fig. [6](#os12572-fig-0006){ref-type="fig"}). There was no evidence of heterogeneity among the included studies (I^2^ = 16.2%, *P* = 0.309).

![Forest plot showing the effect of high BMI on SF‐36 PCS.](OS-12-3-g006){#os12572-fig-0006}

*SF‐36 MCS* {#os12572-sec-0020}
-----------

Two studies[14](#os12572-bib-0014){ref-type="ref"}, [25](#os12572-bib-0025){ref-type="ref"} with six sets of data reported the SF‐36 MCS. The aggregated results showed that high BMI was associated with a similar SF‐36 MCS score as normal BMI (WMD = −0.87, 95%CI: −2.09, 0.35; *P* = 0.164) (Fig. [7](#os12572-fig-0007){ref-type="fig"}). There was no significant heterogeneity among the included studies (I^2^ = 0.0%, *P* = 0.478).

![Forest plot showing the effect of high BMI on SF‐36 MCS.](OS-12-3-g007){#os12572-fig-0007}

*Cardiac Complications* {#os12572-sec-0021}
-----------------------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with eight sets of data reported cardiac complications. Pooled estimate showed that high BMI was associated with a significantly higher rate of cardiac complications than normal BMI (RR = 1.30, 95% CI: 1.11, 1.52; *P* = 0.001) (Fig. [8](#os12572-fig-0008){ref-type="fig"}). The test for heterogeneity was not significant (I^2^ = 0.0%, *P* = 0.822).

![Forest plot showing the effect of high BMI on cardiac complications.](OS-12-3-g008){#os12572-fig-0008}

*Mortality* {#os12572-sec-0022}
-----------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with seven sets of data reported the mortality rate. Pooled estimate showed that high BMI was associated with a significantly higher mortality rate than normal BMI (RR = 3.01, 95% CI: 2.75, 3.29; *P* \< 0.001) (Fig. [9](#os12572-fig-0009){ref-type="fig"}). There was no significant heterogeneity (I^2^ = 46.0%, *P* = 0.085).

![Forest plot showing the effect of high BMI on mortality.](OS-12-3-g009){#os12572-fig-0009}

*Central Nervous System (CNS) Complications* {#os12572-sec-0023}
--------------------------------------------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with eight sets of data reported the CNS complications. Pooled estimate suggested that high BMI was associated with a similar rate of CNS complications than normal BMI (RR = 0.68, 95% CI: 0.17, 2.76; *P* = 0.586) (Fig. [10](#os12572-fig-0010){ref-type="fig"}). The test for heterogeneity was significant (I^2^ = 88.0%, *P* \< 0.005).

![Forest plot showing the effect of high BMI on CNS complications.](OS-12-3-g010){#os12572-fig-0010}

*Deep Venous Thromboembolism* {#os12572-sec-0024}
-----------------------------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with seven sets of data reported DVT. The pooled estimate showed that high BMI was associated with a higher rate of DVT than normal BMI (RR = 2.29, 95% CI: 1.36, 3.86; *P* = 0.002) (Fig. [11](#os12572-fig-0011){ref-type="fig"}). The test for heterogeneity was significant (I^2^ = 51.8%, *P* = 0.053).

![Forest plot showing the effect of high BMI on deep venous thromboembolism.](OS-12-3-g011){#os12572-fig-0011}

*Pulmonary Complications* {#os12572-sec-0025}
-------------------------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with eight sets of data reported pulmonary complications. The pooled results demonstrated that high BMI was associated with a similar rate of pulmonary complications (RR = 1.46, 95% CI: 0.87, 2.46; *P* = 0.150) (Fig. [12](#os12572-fig-0012){ref-type="fig"}). The test for heterogeneity was significant (I^2^ = 65.2%, *P* = 0.001).

![Forest plot showing the effect of high BMI on pulmonary complications.](OS-12-3-g012){#os12572-fig-0012}

*Septic Complications* {#os12572-sec-0026}
----------------------

Two studies[22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with five sets of data reported the septic complications. The pooled results showed that the septic complication rate was comparable between higher BMI and normal BMI groups (RR = 0.87, 95% CI: 0.32, 2.38; *P* = 0.785) (Fig. [13](#os12572-fig-0013){ref-type="fig"}). The test for heterogeneity was not significant (I^2^=0.0%, *P* = 0.755).

![Forest plot showing the effect of high BMI on septic complications.](OS-12-3-g013){#os12572-fig-0013}

*Wound Complications* {#os12572-sec-0027}
---------------------

Three studies[5](#os12572-bib-0005){ref-type="ref"}, [22](#os12572-bib-0022){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"} with seven sets of data reported the wound complications. Pooled estimate suggested that patients with high BMI had a significantly higher rate of wound complications than those with normal BMI (RR = 1.69, 95% CI: 1.26, 2.28; *P* \< 0.001) (Fig. [14](#os12572-fig-0014){ref-type="fig"}). The test for heterogeneity was not significant (I^2^ = 38.2%, *P* = 0.138).

![Forest plot showing the effect of high BMI on wound complications.](OS-12-3-g014){#os12572-fig-0014}

*Subgroup Analysis* {#os12572-sec-0028}
-------------------

We conducted subgroup analysis based on the type of surgical procedure. In patients who underwent ACDF, high BMI had no influence on the surgical outcomes, including hospital stay (WMD = 1.53 days, 95% CI: −0.46, 3.53; *P* = 0.131), surgical time (WMD = 0.94, 95% CI: −1.78, 3.66; *P* = 0.497), cardiac complications (RR = 1.56, 95% CI: 0.79, 3.11; *P* = 0.204), CNS complications (RR = 0.35, 95% CI: 0.04, 3.22; *P* = 0.351), morality rate (RR = 0.56, 95% CI: 0.16, 1.99; *P* = 0.37), DVT (RR = 1.55, 95% CI: 0.84, 2.84; *P* = 0.161), pulmonary complications (RR = 1.76, 95% CI: 0.93, 3.32; *P* = 0.082), wound complications (RR = 1.48, 95% CI: 0.74, 2.98; *P* = 0.268), and septic complications (RR = 1.70, 95% CI: 0.41, 7.10; *P* = 0.464).

Whereas, in patients who underwent posterior cervical fusion, high BMI had adverse effects on hospital stay (WMD = 2.17 days, 95% CI: 1.32, 3.02; *P* \< 0.001), surgical time (WMD = 22.89, 95% CI: 21.42, 24.36; *P* \< 0.001), cardiac complications (RR = 1.28, 95% CI: 1.09, 1.50; *P* = 0.003), and DVT (RR = 5.49, 95% CI: 1.80, 16.73; *P* = 0.003). For other outcomes, such as cardiac complications (RR = 1.28, 95% CI: 1.09, 1.50; *P* = 0.003), CNS (RR = 1.33, 95% CI: 0.79, 2.24; *P* = 0.280), morality (RR = 0.32, 95% CI: 0.04, 2.73; *P* = 0.298), pulmonary complications (RR = 1.15, 95% CI: 0.56, 2.37; *P* = 0.705), wound complications (RR = 1.54, 95% CI: 0.90, 2.64; *P* = 0.113), and septic complications (RR = 0.48, 95% CI: 0.10, 2.20; *P* = 0.330), high BMI had no effect.

We conducted subgroup analysis based on the obesity categories. Compared with nonobese patients, obese III patients had a longer surgical time (WMD = 6.49, 95% CI: 5.92, 7.05; *P* \< 0.001), whereas obese I (WMD = −1.44, 95% CI: −1.59, 0.29; *P* = 0.074) and obese II (WMD = −0.28, 95% CI: −0.57, 0.01; *P* = 0.063) patients did not. There was no significant differences between nonobese and obese I/II/III groups in overall complication rate (RR = 0.89, 95% CI: 0.58, 1.34, *P* = 0.566; RR = 0.90, 95% CI: 0.53, 1.50, *P* = 0.678; RR = 1.10, 95% CI: 0.63, 1.93, *P* = 0.747).

*Publication Bias* {#os12572-sec-0029}
------------------

Since the number of included studies was less than 10, the assessment of publication bias was not performed.

Discussion {#os12572-sec-0030}
==========

The major purpose of present meta‐analysis was to evaluate whether high BMI had adverse effects on the surgical outcomes for patients after cervical fusion procedures. Our results suggested that high BMI was associated with longer hospital stay and surgical time as compared with normal BMI. Additionally, high BMI was associated with increased complication rates, including cardiac complications, mortality, DVT and wound complications. Furthermore, there was no significant differences among high and normal BMI patients in regard to outcomes of cervical fusion procedures, including Neck Disability Index, SF‐36 MCS, overall complications, CNS complications, pulmonary complications, and septic complications. Our results indicated that high BMI might have adverse effects in surgical outcomes in patients who underwent cervical fusion procedures.

To our knowledge, this is the first systematic review and meta‐analysis that investigates the influence of high BMI on the surgical outcome in patients who underwent cervical fusion procedures. There were two systematic review and meta‐analyses[13](#os12572-bib-0013){ref-type="ref"}, [27](#os12572-bib-0027){ref-type="ref"} that examined the effects of obesity on surgical and postoperative outcomes after spine surgery. The findings of the two meta‐analyses were consistent with ours. In the meta‐analysis conducted by Jiang *et al*.[13](#os12572-bib-0013){ref-type="ref"} the authors included 32 studies with 8576 patients who underwent spine surgery. Their results demonstrated that obesity was associated with higher risk of surgical site infection (odds ratio (OR) = 2.33, 95% CI: 1.94, 2.79), venous thromboembolism (OR = 3.15, 95% CI: 1.92, 5.17), mortality (OR = 2.6, 95% CI: 1.50, 4.49), revision rate (OR = 1.43, 95% CI: 1.05, 1.93), longer operation time (OR = 14.55, 95% CI: 10.03, 19.07), and more blood loss (mean difference = 28.89, 95% CI: 14.20, 43.58)[13](#os12572-bib-0013){ref-type="ref"}. These results were in agreement with ours. However, whether this positive relationship could also be seen in the patients undergoing cervical spinal surgery was still unclear since the authors did not separate their results by the level of the spine. Another systematic review[27](#os12572-bib-0027){ref-type="ref"} examined several relevant studies, and also reported similar results to ours. In that study, the authors demonstrated that obese patients who underwent spine surgery were more likely to develop postoperative complications, particularly surgical site infection and venous thromboembolism[27](#os12572-bib-0027){ref-type="ref"}.

In the present meta‐analysis, we found significant heterogeneity in several outcomes among the included studies. Although we performed sensitivity analysis, no significant improvement was found in heterogeneity, which indicated that the pooled estimate in our study was stability. The reliability of our findings regarding the positive relationship between high BMI and adverse outcomes does not seem diminished. This is because, in a meta‐analysis that had small number of included studies and large heterogeneity, the robustness of the finding is best assessed with sensitivity analysis[28](#os12572-bib-0028){ref-type="ref"}.

In the present study, our results suggested that high BMI was associated with longer hospital stay as compared with normal BMI. Our findings were consistent with the results of Kalanithi *et al*.[5](#os12572-bib-0005){ref-type="ref"} but contradicted that of Narain *et al*.[23](#os12572-bib-0023){ref-type="ref"}. Kalanithi *et al*.[5](#os12572-bib-0005){ref-type="ref"} conducted a retrospective cross‐sectional study of 84,607 patients undergoing spinal fusion, and 1455 of them were morbidly obese (≥40 kg/m^2^). Their results demonstrated that hospital stay was significantly longer in the morbid obesity group than normal weight group (4.8 days *vs* 3.5 days, *P* \< 0.001)[5](#os12572-bib-0005){ref-type="ref"}. Conversely, in a study of 277 patients who underwent 1‐ to 2‐lelev ACDF produces, the authors demonstrated similar length of hospital stay between the higher and normal BMI groups[23](#os12572-bib-0023){ref-type="ref"}. In that study, the authors stratified patients by BMI into nonobese (\<25 kg/m^2^), obese I (25.0--29.9 kg/m^2^), obese II (30.0--34.9 kg/m^2^), and obese III (≥35.0 kg/m^2^) groups. The mean length of hospital stay in these groups was 31.9 ± 22.5, 31.5 ± 16.6, 37.2 ± 22.9, and 35.7 ± 18.0 h, respectively[23](#os12572-bib-0023){ref-type="ref"}. There were no significant differences between the obese and nonobese groups.

Surgical time was significantly longer in the high BMI group than in the normal BMI group in this present study. This finding is in agreement with studies regarding the effects of higher BMI (obese III) after cervical fusion procedures. In a retrospective cohort study of 3671, of which 400 patients underwent anterior or posterior cervical fusion, Buerba *et al*.[22](#os12572-bib-0022){ref-type="ref"} demonstrated that surgical time was significantly longer in obese class III patients who underwent anterior (138.75 ± 4.69 *vs* 132.24 ± 1.53) or posterior cervical fusion (200.24 ± 8.04 *vs* 177.35 ± 5.86) than in nonobese patients. However, in obese class I or II patients, this difference was not seen.

In the present study, we found that high BMI was associated with increased postoperative complications, including cardiac complication, DVT, and wound complications. This indicates that patients with high BMI should be counseled carefully about the risks of postoperative complications. Our findings were consistent with much of the literature regarding the effects of obesity on cervical fusion procedures[5](#os12572-bib-0005){ref-type="ref"}, [14](#os12572-bib-0014){ref-type="ref"}, [24](#os12572-bib-0024){ref-type="ref"}. Kalanithi *et al*.[5](#os12572-bib-0005){ref-type="ref"} performed a retrospective cross‐sectional study on 84,607 patients who underwent spinal fusion. They discovered that morbid obesity was associated with 97% higher complication rates than normal weight patients (13.6% *vs* 6.9%), and this was seen in all complication types (cardiac, renal, pulmonary, wound complications)[5](#os12572-bib-0005){ref-type="ref"}. The most common complication type in morbidly obese patients was wound complication (6.0%) and pulmonary complication (5.8%)[5](#os12572-bib-0005){ref-type="ref"}. Phan *et al*.[24](#os12572-bib-0024){ref-type="ref"} also reported similar results, which demonstrated that obese patients (BMI \> 30) who underwent posterior cervical fusion surgery were at an increased risk of VTE. In that study, the authors prospectively collected data from the American College of Surgeons National Surgical Quality Improvement Program (ACSNSQIP), and then analyzed them by univariate analysis and multivariate logistic regression[24](#os12572-bib-0024){ref-type="ref"}. The multivariate analysis showed that obesity was an independent predictor for VTE (OR = 6.15, 95% CI: 1.26, 30.20; *P* = 0.02)[24](#os12572-bib-0024){ref-type="ref"}, which was in consistent with our findings.

There were several potential limitations to this study. First, our results were analyzed based on seven studies, some of which had a small sample size. Compared with larger trials, smaller trials were more likely to overestimate the treatment effect. Second, all of the included studies were prospective or retrospective observational trials rather than randomized controlled trials. The inherent nature of observational trials may be associated with selective bias, which might have influences on our results. Third, we tried to conduct subgroup analysis based on obesity categories for all the outcomes. However, only for surgical time, several studies provided available data, and for the remaining outcomes there was paucity of data. Therefore, the subgroup analysis for other outcomes was not performed.

In conclusion, the present meta‐analysis examined the influence of high BMI on the surgical outcomes in patients who underwent cervical fusion procedures. Our study demonstrated significant differences in length of hospital stay, surgical time, mortality rate, cardiac complications, DVT, and wound complications among the high BMI group and normal BMI group after the cervical fusion procedures. Our results suggested that high BMI seemed to increase the rate of adverse outcomes after cervical fusion surgeries.
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